Jon Hollick

Jon Hollick

Company: Breakpoint Therapeutics

Job title: Managing Director & Head of Research

Seminars:

Next Generation DDR/Synthetic Lethality Targets: Mining DNA Metabolism for Gold 3:00 pm

Approaches to drug discovery Overview of Polymerase theta as a tumour selective drug target Exploiting cancer replication stress: spotlight on WRN helicaseRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.